BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36055752)

  • 41. miR-19b enhances proliferation and apoptosis resistance via the EGFR signaling pathway by targeting PP2A and BIM in non-small cell lung cancer.
    Baumgartner U; Berger F; Hashemi Gheinani A; Burgener SS; Monastyrskaya K; Vassella E
    Mol Cancer; 2018 Feb; 17(1):44. PubMed ID: 29455644
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Netrin-1 elicits metastatic potential of non-small cell lung carcinoma cell by enhancing cell invasion, migration and vasculogenic mimicry via EMT induction.
    Zhang X; Cui P; Ding B; Guo Y; Han K; Li J; Chen H; Zhang W
    Cancer Gene Ther; 2018 Feb; 25(1-2):18-26. PubMed ID: 29234153
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Co-treatment with BEZ235 enhances chemosensitivity of A549/DDP cells to cisplatin via inhibition of PI3K/Akt/mTOR signaling and downregulation of ERCC1 expression.
    Xia A; Li H; Li R; Lu L; Wu X
    Oncol Rep; 2018 Oct; 40(4):2353-2362. PubMed ID: 30066933
    [TBL] [Abstract][Full Text] [Related]  

  • 44. POM121 promotes proliferation and metastasis in non-small-cell lung cancer through TGF-β/SMAD and PI3K/AKT pathways.
    Guan L; Zhang L; Wang T; Jia L; Zhang N; Yan H; Zhao K
    Cancer Biomark; 2021; 32(3):293-302. PubMed ID: 34151840
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Thrombin is a therapeutic target for non-small-cell lung cancer to inhibit vasculogenic mimicry formation.
    Zhao B; Wu M; Hu Z; Ma Y; Qi W; Zhang Y; Li Y; Yu M; Wang H; Mo W
    Signal Transduct Target Ther; 2020 Jul; 5(1):117. PubMed ID: 32647187
    [TBL] [Abstract][Full Text] [Related]  

  • 46. SHP-2-upregulated ZEB1 is important for PDGFRα-driven glioma epithelial-mesenchymal transition and invasion in mice and humans.
    Zhang L; Zhang W; Li Y; Alvarez A; Li Z; Wang Y; Song L; Lv D; Nakano I; Hu B; Cheng SY; Feng H
    Oncogene; 2016 Oct; 35(43):5641-5652. PubMed ID: 27041571
    [TBL] [Abstract][Full Text] [Related]  

  • 47. IRS4 promotes the progression of non-small cell lung cancer and confers resistance to EGFR-TKI through the activation of PI3K/Akt and Ras-MAPK pathways.
    Hao P; Huang Y; Peng J; Yu J; Guo X; Bao F; Dian Z; An S; Xu TR
    Exp Cell Res; 2021 Jun; 403(2):112615. PubMed ID: 33894221
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Highly expressed long non-coding RNA CRNDE promotes cell proliferation through PI3K/AKT signalling in non-small cell lung carcinoma.
    Liu XX; Xiong HP; Huang JS; Qi K; Xu JJ
    Clin Exp Pharmacol Physiol; 2017 Aug; 44(8):895-902. PubMed ID: 28477368
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antihelminthic drug niclosamide inhibits CIP2A and reactivates tumor suppressor protein phosphatase 2A in non-small cell lung cancer cells.
    Kim MO; Choe MH; Yoon YN; Ahn J; Yoo M; Jung KY; An S; Hwang SG; Oh JS; Kim JS
    Biochem Pharmacol; 2017 Nov; 144():78-89. PubMed ID: 28813646
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Zinc finger E-box binding homeobox 1 promotes vasculogenic mimicry in colorectal cancer through induction of epithelial-to-mesenchymal transition.
    Liu Z; Sun B; Qi L; Li H; Gao J; Leng X
    Cancer Sci; 2012 Apr; 103(4):813-20. PubMed ID: 22212097
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neogenin-1 Promotes Cell Proliferation, Motility, and Adhesion by Up-Regulation of Zinc Finger E-Box Binding Homeobox 1 Via Activating the Rac1/PI3K/AKT Pathway in Gastric Cancer Cells.
    Qu H; Sun H; Wang X
    Cell Physiol Biochem; 2018; 48(4):1457-1467. PubMed ID: 30064133
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long non-coding RNA BC087858 induces non-T790M mutation acquired resistance to EGFR-TKIs by activating PI3K/AKT and MEK/ERK pathways and EMT in non-small-cell lung cancer.
    Pan H; Jiang T; Cheng N; Wang Q; Ren S; Li X; Zhao C; Zhang L; Cai W; Zhou C
    Oncotarget; 2016 Aug; 7(31):49948-49960. PubMed ID: 27409677
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Expression of CD82/KAI1 and HIF-1α in non-small cell lung cancer and their relationship to vasculogenic mimicry].
    Wu S; Cheng Z; Yu L; Song W; Tao Y
    Zhongguo Fei Ai Za Zhi; 2011 Dec; 14(12):918-25. PubMed ID: 22152691
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PP2A inhibition is a druggable MEK inhibitor resistance mechanism in KRAS-mutant lung cancer cells.
    Kauko O; O'Connor CM; Kulesskiy E; Sangodkar J; Aakula A; Izadmehr S; Yetukuri L; Yadav B; Padzik A; Laajala TD; Haapaniemi P; Momeny M; Varila T; Ohlmeyer M; Aittokallio T; Wennerberg K; Narla G; Westermarck J
    Sci Transl Med; 2018 Jul; 10(450):. PubMed ID: 30021885
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway.
    Gong T; Cui L; Wang H; Wang H; Han N
    J Transl Med; 2018 Jun; 16(1):164. PubMed ID: 29898734
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MicroRNA-520a-3p inhibits cell growth and metastasis of non-small cell lung cancer through PI3K/AKT/mTOR signaling pathway.
    Lv X; Li CY; Han P; Xu XY
    Eur Rev Med Pharmacol Sci; 2018 Apr; 22(8):2321-2327. PubMed ID: 29762835
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ZEB1 serves as an oncogene in acute myeloid leukaemia via regulating the PTEN/PI3K/AKT signalling pathway by combining with P53.
    Li L; Feng Y; Hu S; Du Y; Xu X; Zhang M; Peng X; Chen F
    J Cell Mol Med; 2021 Jun; 25(11):5295-5304. PubMed ID: 33960640
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MicroRNA-107 inhibits tumor growth and metastasis by targeting the BDNF-mediated PI3K/AKT pathway in human non-small lung cancer.
    Xia H; Li Y; Lv X
    Int J Oncol; 2016 Oct; 49(4):1325-33. PubMed ID: 27498977
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Upregulation of LncRNA-HIT promotes migration and invasion of non-small cell lung cancer cells by association with ZEB1.
    Jia X; Wang Z; Qiu L; Yang Y; Wang Y; Chen Z; Liu Z; Yu L
    Cancer Med; 2016 Dec; 5(12):3555-3563. PubMed ID: 27790864
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Curcumin suppresses vasculogenic mimicry capacity of hepatocellular carcinoma cells through STAT3 and PI3K/AKT inhibition.
    Chiablaem K; Lirdprapamongkol K; Keeratichamroen S; Surarit R; Svasti J
    Anticancer Res; 2014 Apr; 34(4):1857-64. PubMed ID: 24692720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.